GI cancer study using a lab tumor model from your surgery
Part of Cancer, Digestive system clinical trials.
This study uses a special lab model made from tumor tissue taken during a planned standard cancer surgery. It tests how well the lab model can represent your cancer, which may help researchers improve future treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a tumor coming from the gastrointestinal (GI) tract (like stomach or intestines)
- You have a surgery already planned as part of your usual care (standard of care procedure)
- You are 18 years old or older
- You can understand the study and sign written informed consent
- You are able and willing to follow the study plan as directed by the team
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses a small sample of your tumor to grow it in the lab, which may help researchers understand your cancer better and find treatments that work for you.
This study collects medical information from people with gastrointestinal (GI) cancer, both those treated in the past and those currently receiving care. The goal is to learn more about the disease and improve future treatments.
This trial takes a small sample of your tumor to grow a model in the lab. This model helps doctors test which treatments might work best for you.
This trial collects and studies tumor and lymph node samples from people with gastric cancer who have had chemotherapy and surgery. The goal is to understand how cancer responds to treatment and to improve future care.
This study collects clinical and lab information to better understand metastatic cancers of the digestive system and how patients respond to treatment. It may help improve future care, but it is mainly focused on collecting data rather than testing a new drug.
This study collects medical information and small tissue or fluid samples from people with peritoneal (abdominal lining) cancer. It aims to better understand the disease and improve future care plans.
Hear when a new Peritoneal Carcinomatosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.